Drawing for INTEGRATED MANUFACTURING BY HELSINN

USPTO serial 77270711

INTEGRATED MANUFACTURING BY HELSINN

Reviewed by CopyMark Law Group

Reg. 3633675Status 710
Filing date
Status date
Registration date
Jun 9, 2009
Examiner
CRAWFORD, MARY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INTEGRATED MANUFACTURING BY HELSINN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amanda Laura Nye

Amanda Laura Nye LAWYERS AT LARGE LLC6 Davis Drive Apt ETIBURON, CA 94920-2005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for use in developing anti-inflammatory drugs, antiemetic drugs, drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancers, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders, drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceutical purposesSECTION 8 - CANCELLED—
005Pharmaceutical preparations and substances, namely, anti-inflammatory drugs, antiemetic drugs, drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancers, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin, drugs for internal cleansing purposes, bowel cleansers and evacuants; chemical reagents for medical purposes; chemico-pharmaceuticals, namely, anti-inflammatory drugs, antiemetic drugs, drugs for the treatment of cancer, carcinoma, leukemia, lymphoma, melanoma, anti-tumor drugs, drugs for use in case of ulcerative and inflammatory conditions, anti-anxiety drugs, anti-migraine drugs, cognition enhancers, drugs for the prevention and treatment of gastroenterological, hepatologic, nephrologic and cardiovascular disorders of any origin, drugs for internal cleansing purposes, bowel cleansers and evacuants for medical and pharmaceutical purposesSECTION 8 - CANCELLED—
035Advertising, marketing, and promotion services related to the pharmaceutical field; commercial administration of the licensing of goods and services for others related to the pharmaceutical fieldSECTION 8 - CANCELLED—
040Treatment of materials, namely, the treatment and synthesis of raw materials and semi-finished materials to produce an active drug constituent for use in the development of pharmaceuticals; treatment of materials, namely, the manufacture of pharmaceuticals for others through the treatment and formulation of active drug constituents with excipients; consultancy services in connection with the treatment of materials in the pharmaceutical synthesis and manufacturing processesSECTION 8 - CANCELLED—
042Scientific research and development; pharmaceutical research and development, namely, development of drugs and active principles; medical research; biological development, namely, development of biotechnology products for others; medical development, namely, clinical development of drugsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 15, 2016C8..CANCELLED SEC. 8 (6-YR)—
Mar 13, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 9, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 24, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2009NPUBNOTICE OF PUBLICATION—
Feb 18, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 17, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 17, 2009XAECEXAMINER'S AMENDMENT ENTERED—
Feb 17, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 17, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 17, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 24, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2008ALIEASSIGNED TO LIE—
Jun 10, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2007DOCKASSIGNED TO EXAMINER—
Sep 7, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance